Zavain is driven by smart software, leveraging data and machine intelligence to scale, augment, and balance human intelligence. He invests in companies that are using machine learning and AI to augment or replace physical-world functions including biology, language, manufacturing and analysis. He looks for entrepreneurs that can use software and data to hone a philosophical position on where the world is, and how to direct it for the better.
Partner of The Stevenson Group (TSG) since 2015, Kristine has nearly 20 years in Life Sciences executive search. She partners with clients ranging from Pre-Series A ventures to commercial stage life sciences companies across multiple functional areas, from R&D departments to commercial teams, as well as recruiting C-Level executives and Non-Executive Board members. Kristine also leads TSG’s Diversity Initiative with an emphasis on female leadership. Working closely with Women in Bio’s Boardroom Ready Program, Kristine is committed to increasing gender diversity on Boards. She is also a member of WIB’s inaugural National Diversity and Inclusion Resource Group.
he is British motor racing engineer and former chief engineer of the McLaren Formula One team. Morris graduated from Coventry University with a degree in mechanical engineering, joining Cosworth soon after. He remained at Cosworth until 2006, after which he joined Williams, where he stayed for eight years before joining Sauber in 2011. Morris quickly rose up the ranks at Sauber to become their chief designer, a position he held for two seasons before moving back to the UK as McLaren's chief engineer in 2013, a role he held until 26 July 2018 when he resigned.
Startup executive experienced in launching pioneering technology products, building high performing teams, and scaling companies from zero to later stage revenue growth $100M+. Early employee and executive leader at 5 VC-backed startups: two IPOs, one $1B acquisition, two $500M+ valuations. Highly effective in navigating new market categories, and successfully achieving market leadership. Demonstrated leadership in go-to-market strategy, product definition and development, brand development, marketing and sales enablement.
Alex joined Oxford Science Enterprises as Head of Corporate Finance in October 2019. He was previously a medical student at the University of Oxford and a junior doctor in Oxford before joining investment banking in 2007. Over the course of 13 years, he worked on M&A and capital raising across healthcare, as well as energy and infrastructure. He worked at UBS and then Lazard in Europe and the Australia Pacific region. His experience includes both large pharma and medtech clients as well as early stage biotech and digital health, traditional and renewable energy generation and transmission for private and public market clients. Alex co-ordinates all fundraising and exits across the enterprises, manages the Investment Committee process and reports on the Investment Portfolio. He represents Oxford Science Enterprises on the boards of Vaccitech and Macrophox and is an observer on the board of Evox Therapeutics.
Commercial product executive with strong wireless / mobile, communications and internet consumer applications experience and proven track record of delivering innovative amazing products and customer experiences. Strong technical and product background and strong track record in business development globally.
As Head of Life Sciences I bring together the specialist skills of professionals at JLL to address major strategic and operational opportunities and challenges within the life sciences sector. Awarded an MBE for services to the biotech industry in 2014.
My mission, through nurturing the BioEscalator community, is to drive positive impact on the Oxford biomedical innovation ecosystem. Following an academic career in chemistry and cancer research, culminating in postdoctoral work in a joint-venture biotech start-up at the University of Edinburgh, Claire’s career has focused on multidisciplinary team management in the biomedical and university sector. Formerly Head of Strategic Intelligence at an Oxford-based pharmaceutical consultancy company, Claire then joined the University of Oxford in 2008, working in research and departmental management in Experimental Medicine and Oncology. Claire took up her role in the BioEscalator as it opened in September 2018. Following an academic career in chemistry and cancer research, culminating in postdoctoral work in a joint-venture biotech start-up at the University of Edinburgh, Claire’s career has focused on multidisciplinary team management in the biomedical and university sector. Formerly Head of Strategic Intelligence at an Oxford-based pharmaceutical consultancy company, Claire then joined the University of Oxford in 2008, working in research and departmental management in Experimental Medicine and Oncology. Claire took up her role in the BioEscalator as it opened in September 2018.
A trusted confidant of the C-suite, Kathryn is known for her ability to dissect problems and offer simple, yet unseen solutions. Kathryn has a passion for people and operations that’s led her to high-impact roles in fast-paced organizations.
Founder of Peloton, an executive search and advisory group that builds Boards and executive teams for early and growth-stage Technology and Engineering businesses in the UK and Europe.
William “Bill” Enright is a seasoned biotech executive with more than thirty years of experience in building and financing both privately held and publicly held companies. Bill spent more than ten years at Altimmune (NASDAQ: ALT) as a Director, President & CEO, moving multiple programs into clinical testing, completing several acquisitions and eventually taking the company public. Prior to joining Altimmune, Bill spent six years with GenVec, Inc. (acquired by Intrexon) with increasing responsibilities, which included a role as Head of Business Development. He currently serves on the Board of Directors of Gravitas Therapeutics, Inc.
Guissu is deeply motivated by a desire to make a lasting impact for companies and the individuals within. After a decade-long legal career as an employment attorney and litigator at the international law firm Littler Mendelson, global payments company Visa and on-demand grocery delivery start-up Instacart, Guissu pursued her passion for people and business strategy to build up the People team at Instacart.
